Back
Product details:
CAS
906673-24-3
Purity
95%
Crisaborole has broad-spectrum anti-inflammatory activity by mainly targeting phosphodiesterase 4 (PDE4) enzyme that is a key regulator of inflammatory cytokine production. It is intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
Properties
Name
Crisaborole
Smiles
OB1OCC=2C=C(OC=3C=CC(C#N)=CC3)C=CC12
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole | AN2728 | crisaborole
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$55
35 mg
$58
40 mg
$60
45 mg
$63
50 mg
$65
75 mg
$68
100 mg
$POA
Quantity
1
Total amount
$ 41
5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole | AN2728 | crisaborole
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.